FDA Adverse Event Malfunction Summary report: N

PROMUS ELEMENT? PLUS

MDR report key: 3963628 · Received July 29, 2014

Report

Report Number
2134265-2014-04395
Event Type
Malfunction
Date Received
July 29, 2014
Date of Event
May 21, 2014
Report Date
July 4, 2014
Manufacturer
BOSTON SCIENTIFIC - GALWAY
Product Code
NIQ
PMA / PMN Number
P110010
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
IN
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

AGE AT TIME OF EVENT: 18 YEARS OR OLDER. DEVICE IS A COMBINATION PRODUCT. (B)(4). DEVICE EVALUATED BY MANUFACTURER: A VISUAL AND TACTILE EXAMINATION OF THE DEVICE FOUND THAT THE STENT WAS DAMAGED AT THE DISTAL END; STENT STRUTS WERE FOUND TO BE STRETCHED AND LIFTED UPWARDS FROM ITS PROFILE. NO OTHER ISSUES WERE NOTED WITH THE CRIMPED STENT AND THE BALLOON WAS TIGHTLY WRAPPED AND DID NOT APPEAR TO HAVE BEEN SUBJECTED TO POSITIVE PRESSURE. THE MANUFACTURING BATCH RECORD REVIEW CONFIRMED THAT THE DEVICE MET ALL MATERIAL, ASSEMBLY AND PERFORMANCE SPECIFICATIONS. THE MOST PROBABLE ROOT CAUSE IS OPERATIONAL CONTEXT AS DEVICE PERFORMANCE WAS LIMITED DUE TO ANATOMICAL PROCEDURAL FACTORS. (B)(4).

Description of Event or Problem · 1

REPORTABLE BASED ON ANALYSIS COMPLETED ON (B)(4) 2014. IT WAS REPORTED THAT CATHETER CROSSING DIFFICULTIES WERE ENCOUNTERED.  THE TARGET LESION WAS LOCATED IN THE MODERATELY TORTUOUS RIGHT CORONARY ARTERY (RCA). FOLLOWING PRE-DILATION USING AN UNSPECIFIED BALLOON CATHETER, A 2.75X16MM PROMUS ELEMENT¿ PLUS STENT WAS ADVANCED HOWEVER, RESISTANCE WAS ENCOUNTERED AND THE DEVICE WAS UNABLE TO CROSS THE LESION. THE PROCEDURE WAS COMPLETED WITH A NON BSC DEVICE. NO PATIENT COMPLICATIONS WERE REPORTED AND THE PATIENT'S STATUS WAS STABLE. HOWEVER, RETURNED DEVICE ANALYSIS REVEALED DISTAL STENT DAMAGE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
442109 PROMUS ELEMENT? PLUS STENT, CORONARY, DRUG-ELUTING NIQ BOSTON SCIENTIFIC - GALWAY H7493918416270 15849837

Patients

Seq Age Sex Outcome Treatment
1